Michael E. Klepser
-
- Antibiotic Use and Resistance 18
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility 30
- Antimicrobial Resistance in Staphylococcus 20
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes 13
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 15
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 31
-
- Pneumonia and Respiratory Infections 23
- Fungal Infections and Studies 21
- Co-authors
- Erika J. ErnstMichael A. PfallerRussell E. LewisMichael E. ErnstTeresa Bailey KlepserDonald G. KlepserAlex J. AdamsErika J. Wolfe
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (18 papers)Antimicrobial Agents and Chemotherapy (17 papers)Journal of the American Pharmacists Association (16 papers)
- Partner nations
- United StatesBelgiumSouth Africa
In The Last Decade
Michael E. Klepser
132 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 150
- Applied Microbiology and Biotechnology 478
- Infectious Diseases 2.0k
- Geriatrics and Gerontology 367
- Molecular Medicine 252
- Pharmacology 847
Countries citing papers authored by Michael E. Klepser
This map shows the geographic impact of Michael E. Klepser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Klepser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Klepser more than expected).
Fields of papers citing papers by Michael E. Klepser
This network shows the impact of papers produced by Michael E. Klepser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Klepser. The network helps show where Michael E. Klepser may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael E. Klepser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 9 | |
| 6 | 2020 | 24 | |
| 7 | Review of Pharmacy-Based Management of Uncomplicated Urinary Tract Infections (UTIS) In Community Pharmacy Settings | 2018 | 9 |
| 8 | 2017 | 11 | |
| 9 | 2016 | 27 | |
| 10 | 2016 | 5 | |
| 11 | Quantification of curricular content devoted to point-of- care testing for infectious diseases in schools and colleges of pharmacy in the United States | 2015 | 4 |
| 12 | 2015 | 62 | |
| 13 | 2014 | 52 | |
| 14 | Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis | 2010 | 1 |
| 15 | 2006 | 26 | |
| 16 | 2000 | 104 | |
| 17 | 1997 | 24 | |
| 18 | 1997 | 33 | |
| 19 | 1997 | 4 | |
| 20 | 1997 | 56 |
About Michael E. Klepser
Michael E. Klepser is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Geriatrics and Gerontology, Molecular Medicine and Epidemiology, having authored 135 papers that have together received 4.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Antifungal resistance and susceptibility (30 papers), Pneumonia and Respiratory Infections (23 papers), Fungal Infections and Studies (21 papers), Antimicrobial Resistance in Staphylococcus (20 papers), Antibiotic Use and Resistance (18 papers), Antibiotic Resistance in Bacteria (15 papers) and Pharmaceutical Practices and Patient Outcomes (13 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (478 citations), Infectious Diseases (2.0k citations), Geriatrics and Gerontology (367 citations), Molecular Medicine (252 citations) and Pharmacology (847 citations). Michael E. Klepser has collaborated with scholars based in United States, Belgium and South Africa. Frequent co-authors include Erika J. Ernst, Michael A. Pfaller, Russell E. Lewis, Michael E. Ernst, Teresa Bailey Klepser, Donald G. Klepser, Alex J. Adams, Erika J. Wolfe, Stephanie A. Klepser and Allison M. Dering-Anderson. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Antimicrobial Agents and Chemotherapy, Journal of the American Pharmacists Association, Diagnostic Microbiology and Infectious Disease and Research in Social and Administrative Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.